CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS
February 12, 2025 6:30 AM ESTFourth Quarter Highlights
Total revenues increased to $97.7 billion, up 4.2% compared to prior yearGAAP diluted EPS of $1.30 and Adjusted EPS of $1.19Full-Year Highlights
Total revenues increased to $372.8 billion, up 4.2% compared to prior yearGAAP diluted EPS of $3.66 and Adjusted EPS of $5.42Generated cash flow from operations of $9.1 billion2025 Full-Year Guidance
GAAP diluted EPS guidance range of $4.58 to... More